Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies.

Abstract

Levosimendan might reduce mortality in cardiac surgery and cardiology settings of adult patients.

Full Text

DOI - Critical care medicine (DOI)
Swets Information Services - full-text online
Ovid Technologies, Inc. - full-text online
Lippincott Williams & Wilkins - full-text online

Subjects

Similar articles

Levosimendan preoperative. (2012-12-04)
Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. (2013-04-26)
Levosimendan for the treatment of acute severe heart failure: A meta-analysis of randomised controlled trials. (2008-09-26)
Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects. (2013-04-18)
Facilitation of left ventricular function recovery post percutaneous coronary intervention by levosimendan. (2012-10-11)
Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials. (2013-05-06)
Economic evaluation of levosimendan versus dobutamine for the treatment of acute heart failure in Italy. (2012-12-06)
Levosimendan: beyond its simple inotropic effect in heart failure. (2007-04-19)
Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction. (2008-07-08)
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. (2007-05-02)

Authors

Publication date

2012-01-18

Journal

Critical care medicine
Crit Care Med (1530-0293)

Journal topics

Language

Eng.

Copyright

Critical care medicine

Department of Anesthesia and Intensive Care, Università Vita-Salute San Raffaele, Milano, Italy. landoni.giovanni [at] hsr.it

Release reference

Crit Care Med. 2012 Feb;40(2):634-46

Related books

Español | English

© Galenicom 1999-2013